Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 4,764 | 4,419 | 4,877 | 3,870 | 3,518 |
| Cost of Goods | 1,849 | 1,624 | 1,723 | 1,395 | 1,369 |
| Gross Profit | 2,915 | 2,795 | 3,154 | 2,475 | 2,149 |
| Operating Expenses | 3,450 | 3,171 | 3,311 | 2,553 | 2,312 |
| Operating Income | 314 | 248 | 566 | 317 | 206 |
| Interest Expense | 0 | 1 | 0 | 0 | 0 |
| Other Income | 26 | -1 | -8 | 47 | -23 |
| Pre-tax Income | 340 | 246 | 558 | 364 | 183 |
| Income Tax | 3 | 9 | N/A | N/A | N/A |
| Net Income Continuous | 337 | 237 | 558 | 349 | 183 |
| Net Income | $337 | $237 | $558 | $349 | $183 |
| EPS Basic Total Ops | 0.03 | 0.02 | 0.05 | 0.04 | 0.02 |
| EPS Basic Continuous Ops | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 |
| EPS Diluted Total Ops | 0.03 | 0.02 | 0.05 | 0.04 | 0.02 |
| EPS Diluted Continuous Ops | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 |
| EBITDA(a) | $348 | $281 | $606 | $352 | $239 |